SG&A Expense (Quarterly) Chart

Historical SG&A Expense (Quarterly) Data

View and export this data back to 1999. Upgrade now.
Date Value
December 31, 2023 3.084M
September 30, 2023 3.311M
June 30, 2023 3.292M
March 31, 2023 3.523M
December 31, 2022 2.625M
September 30, 2022 3.756M
June 30, 2022 3.033M
March 31, 2022 3.573M
December 31, 2021 4.736M
September 30, 2021 3.496M
June 30, 2021 2.884M
March 31, 2021 3.091M
December 31, 2020 3.310M
September 30, 2020 2.783M
June 30, 2020 2.589M
March 31, 2020 2.286M
December 31, 2019 2.373M
September 30, 2019 2.260M
June 30, 2019 2.407M
March 31, 2019 2.529M
December 31, 2018 3.082M
September 30, 2018 3.572M
June 30, 2018 2.882M
March 31, 2018 1.997M
December 31, 2017 2.593M
Date Value
September 30, 2017 2.790M
June 30, 2017 3.403M
March 31, 2017 3.230M
December 31, 2016 3.901M
September 30, 2016 2.623M
June 30, 2016 2.577M
March 31, 2016 2.523M
December 31, 2015 3.169M
September 30, 2015 3.086M
June 30, 2015 3.223M
March 31, 2015 2.901M
December 31, 2014 4.672M
September 30, 2014 3.156M
June 30, 2014 2.948M
March 31, 2014 3.298M
December 31, 2013 3.846M
September 30, 2013 2.682M
June 30, 2013 3.241M
March 31, 2013 2.754M
December 31, 2012 2.521M
September 30, 2012 1.886M
June 30, 2012 1.752M
March 31, 2012 1.825M
December 31, 2011 2.152M
September 30, 2011 3.860M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (Quarterly) Range, Past 5 Years

2.260M
Minimum
Sep 2019
4.736M
Maximum
Dec 2021
3.074M
Average
3.084M
Median
Dec 2023

SG&A Expense (Quarterly) Benchmarks

Fonar Corp 5.587M
XWELL Inc 6.392M
ProPhase Labs Inc 8.022M
Veracyte Inc 48.21M
OncoCyte Corp 2.391M